In this report, case 2, with both BRCA1 and BRCA2 germline mutations, showed high response of platinum-based chemotherapy for lymph node recurrence and long-term survival after the recurrence, in a manner similar to BRCA1/2-mutated ovarian and breast cancers. The gene discussed is BRCA2; the disease is breast carcinoma.